By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


NxStage/Fresenius Likely Next Test for Divided Commission

The U.S. Federal Trade Commission has been reviewing Fresenius’ $2 billion acquisition of NxStage Medical for nearly a year and a half, making it the longest deal under review at the agency.featured

Customers Comment on PacBio/Illumina

Sources told CTFN that Pacific Biosciences reached out to customers in early December to alert them that they may be contacted by the U.S. Federal Trade Commission regarding the company’s acquisition by Illumina.featured

FTC Likely to Require Firewall for Essendant/Staples Deal

Industry sources told CTFN that the U.S. Federal Trade Commission is likely to require a behavioral remedy in the form of a firewall between Essendant and Staples, in conjunction withfeatured

Deals Delayed as Government Shutdown Continues

The partial U.S. government shutdown is now entering its third week, and new spending packages have not yet moved Congress and the president to reopen nine unfunded federal departments, including the Federal Trade Commission and thefeatured

Nonessential FTC Employees to be Furloughed

At 11:59 p.m. on December 28, 2018, nonessential employees at the U.S. Federal Trade Commission will be furloughed as a result of the government shutdown, the regulatory agency confirmed to CTFN.featured

FTC Decision on NxStage/Fresenius Nears

A decision from the U.S. Federal Trade Commission regarding the acquisition of NxStage Medical by Fresenius is expected any day, FTC sources told CTFN.featured

NxStage/Fresenius Merger: FTC Update

A recommendation to approve a consent order that would allow Fresenius to move forward with its acquisition of NxStage moved from the Federal Trade Commission’s Bureau of Competition to thefeatured

Proposed NxStage/Fresenius Settlement Agreement Advanced to Commissioners

A proposed settlement agreement resolving the FTC’s Bureau of Competition’s concerns with Fresenius’s acquisition of NxStage appears to have passed to the commissioner levelfeatured

Peritoneal Divestiture Also Required in Fresenius Acquisition of NxStage

The review by the U.S. Federal Trade Commission of the acquisition of NxStage by Fresenius is on track and moving forward, according to a source familiar with the matter.featured

Linde/Praxair One Step Closer to Completing Merger

The Korea Fair Trade Commission on October 3 issued a preliminary approval with additional demands for the Linde/Praxair merger, another step forward for the $83 billion transaction.featured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.